Health Canada inspection
Shiseido America Inc.: Health Canada inspection of Dec 3, 2024
Health Canada · GMP · rating I
Key facts
| Establishment | Shiseido America Inc. |
|---|---|
| City | East Windsor |
| Province | NJ |
| Country | United States |
| Program | GMP |
| Start date | Nov 26, 2024 |
| End date | Dec 3, 2024 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.